165 related articles for article (PubMed ID: 28837117)
1. Preclinical Assessment of a
Ebenhan T; Mokaleng BB; Venter JD; Kruger HG; Zeevaart JR; Sathekge M
Molecules; 2017 Aug; 22(9):. PubMed ID: 28837117
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, 68Ga-radiolabeling, and preliminary in vivo assessment of a depsipeptide-derived compound as a potential PET/CT infection imaging agent.
Mokaleng BB; Ebenhan T; Ramesh S; Govender T; Kruger HG; Parboosing R; Hazari PP; Mishra AK; Marjanovic-Painter B; Zeevaart JR; Sathekge MM
Biomed Res Int; 2015; 2015():284354. PubMed ID: 25699267
[TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of 68Ga-labeled 1,4,7-triazacyclononane-1,4,7-triacetic acid-ubiquicidin as a radioligand for PET infection imaging.
Ebenhan T; Zeevaart JR; Venter JD; Govender T; Kruger GH; Jarvis NV; Sathekge MM
J Nucl Med; 2014 Feb; 55(2):308-14. PubMed ID: 24434293
[TBL] [Abstract][Full Text] [Related]
4. (68)Ga-radiopharmaceuticals for PET imaging of infection and inflammation.
Kumar V; Boddeti DK
Recent Results Cancer Res; 2013; 194():189-219. PubMed ID: 22918761
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of bifunctional chelates for the development of gallium-based radiopharmaceuticals.
Ferreira CL; Lamsa E; Woods M; Duan Y; Fernando P; Bensimon C; Kordos M; Guenther K; Jurek P; Kiefer GE
Bioconjug Chem; 2010 Mar; 21(3):531-6. PubMed ID: 20175523
[TBL] [Abstract][Full Text] [Related]
6. Gallium-68 labeled Ubiquicidin derived octapeptide as a potential infection imaging agent.
Bhatt J; Mukherjee A; Shinto A; Koramadai Karuppusamy K; Korde A; Kumar M; Sarma HD; Repaka K; Dash A
Nucl Med Biol; 2018; 62-63():47-53. PubMed ID: 29883883
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of
Boddeti DK; Kumar V
World J Nucl Med; 2021; 20(3):266-272. PubMed ID: 34703395
[TBL] [Abstract][Full Text] [Related]
8. Radiosynthesis and pre-clinical evaluation of [
Chopra S; Singh B; Koul A; Mishra AK; Robu S; Kaur A; Ghai A; Caplash N; Wester HJ
Appl Radiat Isot; 2019 Jul; 149():9-21. PubMed ID: 31003040
[TBL] [Abstract][Full Text] [Related]
9. Preclinical Comparative Study of (68)Ga-Labeled DOTA, NOTA, and HBED-CC Chelated Radiotracers for Targeting PSMA.
Ray Banerjee S; Chen Z; Pullambhatla M; Lisok A; Chen J; Mease RC; Pomper MG
Bioconjug Chem; 2016 Jun; 27(6):1447-55. PubMed ID: 27076393
[TBL] [Abstract][Full Text] [Related]
10. Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancer.
Chatalic KL; Franssen GM; van Weerden WM; McBride WJ; Laverman P; de Blois E; Hajjaj B; Brunel L; Goldenberg DM; Fehrentz JA; Martinez J; Boerman OC; de Jong M
J Nucl Med; 2014 Dec; 55(12):2050-6. PubMed ID: 25413139
[TBL] [Abstract][Full Text] [Related]
11. In Vivo Evaluation of ¹⁸F-SiFAlin-Modified TATE: A Potential Challenge for ⁶⁸Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET.
Niedermoser S; Chin J; Wängler C; Kostikov A; Bernard-Gauthier V; Vogler N; Soucy JP; McEwan AJ; Schirrmacher R; Wängler B
J Nucl Med; 2015 Jul; 56(7):1100-5. PubMed ID: 25977461
[TBL] [Abstract][Full Text] [Related]
12. (68)Ga-labeled DOTA-peptides and (68)Ga-labeled radiopharmaceuticals for positron emission tomography: current status of research, clinical applications, and future perspectives.
Breeman WA; de Blois E; Sze Chan H; Konijnenberg M; Kwekkeboom DJ; Krenning EP
Semin Nucl Med; 2011 Jul; 41(4):314-21. PubMed ID: 21624565
[TBL] [Abstract][Full Text] [Related]
13. Comparative Evaluation of Using NOTA and DOTA Derivatives as Bifunctional Chelating Agents in the Preparation of
Guleria M; Das T; Amirdhanayagam J; Sarma HD; Dash A
Cancer Biother Radiopharm; 2018 Feb; 33(1):8-16. PubMed ID: 29373046
[TBL] [Abstract][Full Text] [Related]
14. 68Ga-DOTA-Siglec-9--a new imaging tool to detect synovitis.
Virtanen H; Autio A; Siitonen R; Liljenbäck H; Saanijoki T; Lankinen P; Mäkilä J; Käkelä M; Teuho J; Savisto N; Jaakkola K; Jalkanen S; Roivainen A
Arthritis Res Ther; 2015 Nov; 17():308. PubMed ID: 26530096
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Neuropeptide Y1 Receptor for Cancer Imaging by Positron Emission Tomography Using Novel Truncated Peptides.
Zhang C; Pan J; Lin KS; Dude I; Lau J; Zeisler J; Merkens H; Jenni S; Guérin B; Bénard F
Mol Pharm; 2016 Nov; 13(11):3657-3664. PubMed ID: 27669056
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase 9 targeting peptides: syntheses, 68Ga-labeling, and preliminary evaluation in a rat melanoma xenograft model.
Ujula T; Huttunen M; Luoto P; Peräkylä H; Simpura I; Wilson I; Bergman M; Roivainen A
Bioconjug Chem; 2010 Sep; 21(9):1612-21. PubMed ID: 20795647
[TBL] [Abstract][Full Text] [Related]
17. Preliminary experience with (68)Ga-DOTA-lanreotide positron emission tomography.
Traub-Weidinger T; Von Guggenberg E; Dobrozemsky G; Kendler D; Eisterer W; Bale R; Putzer D; Gabriel M; Virgolini I
Q J Nucl Med Mol Imaging; 2010 Feb; 54(1):52-60. PubMed ID: 20168286
[TBL] [Abstract][Full Text] [Related]
18. Preparation of ⁶⁸Ga-labelled DOTA-peptides using a manual labelling approach for small-animal PET imaging.
Romero E; Martínez A; Oteo M; García A; Morcillo MA
Appl Radiat Isot; 2016 Jan; 107():113-120. PubMed ID: 26492321
[TBL] [Abstract][Full Text] [Related]
19. Preparation and
Polyak A; Naszalyi Nagy L; Mihaly J; Görres S; Wittneben A; Leiter I; Bankstahl JP; Sajti L; Kellermayer M; Zrínyi M; Ross TL
J Pharm Biomed Anal; 2017 Apr; 137():146-150. PubMed ID: 28119212
[TBL] [Abstract][Full Text] [Related]
20. Targeting of vascular adhesion protein-1 by positron emission tomography visualizes sites of inflammation in Borrelia burgdorferi-infected mice.
Siitonen R; Pietikäinen A; Liljenbäck H; Käkelä M; Söderström M; Jalkanen S; Hytönen J; Roivainen A
Arthritis Res Ther; 2017 Nov; 19(1):254. PubMed ID: 29166944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
